Cargando…
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles()
Pancreatic cancer remains one of the most intractable cancers, with a dismal prognosis reflected by a 5-year survival of ~ 6%. Since early disease symptoms are undefined and specific biomarkers are lacking, about 80% of patients present with advanced, inoperable tumors that represent a daunting chal...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486738/ https://www.ncbi.nlm.nih.gov/pubmed/26055177 http://dx.doi.org/10.1016/j.tranon.2015.03.011 |